Literature DB >> 23011780

Mechanisms associated to impaired activity of cardiac P-type ATPases in endothelial nitric oxide synthase knockout mice.

Daniele C Rezende1, Elisa S C Pôças, Humberto Muzi-Filho, Valéria M N Cunha, Afonso Caricati-Neto, Aron Jurkiewicz, François Noël, Luis E M Quintas.   

Abstract

The effect of long-lasting in vivo restriction of nitric oxide (NO) bioavailability on cardiac and renal P-type ATPases critical for intracellular ion homeostasis is controversial. Previous work has shown in eNOS knockout (eNOS(-/-)) mice hearts that Na(+)/K(+)- and Ca(2+)-ATPase activities were depressed but the underlying mechanisms are still unclear. The goal of this study was to characterize potential alterations responsible for impaired enzyme activity in eNOS(-/-) mice. Na(+)/K(+)-ATPase activity from crude preparations of adult male eNOS(-/-) mice hearts and kidneys was reduced compared with wild-type animals (32 %, p < 0.05 and 16 %, p < 0.0001, respectively). Immunoblot analysis showed that although the expression of the predominant (or exclusive, for the kidney) Na(+)/K(+)-ATPase α1 isoform was not significantly changed, there was an important downregulation of the less abundant α2 isoform in the heart (57 %, p < 0.0001). In addition, although cardiac Ca(2+)-ATPase activity was unaltered, the expression of sarco/endoplasmic reticulum Ca(2+)-ATPase 2 protein in eNOS(-/-) mice was very high (290 % compared with wild-type animals, p < 0.0001) without any significant change in phospholamban expression. Consistent with these findings, the content of cardiac and renal free sulfhydryl groups, essential for the catalytic function of such ATPases, was decreased (23 %, p < 0.01 and 35 %, p < 0.05, respectively). Altogether, the present results suggest that the absence of eNOS promotes a compartmentalized altered redox balance that affects the activity and expression of ion transport ATPases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23011780     DOI: 10.1007/s13105-012-0203-x

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  44 in total

1.  Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3.

Authors:  Hunter C Champion; Dimitrios Georgakopoulos; Eiki Takimoto; Takayoshi Isoda; Yibin Wang; David A Kass
Journal:  Circ Res       Date:  2004-01-29       Impact factor: 17.367

2.  Insights into the mechanism of Na+,K+-ATPase inhibition by 2-methoxy-3,8,9-trihydroxy coumestan.

Authors:  Elisa S C Pôças; Natália A Touza; Paulo H C Pimenta; Fernanda B Leitão; Chaquip D Neto; Alcides J M da Silva; Paulo R R Costa; François Noël
Journal:  Bioorg Med Chem       Date:  2008-09-07       Impact factor: 3.641

3.  Studies on the specificity of the effects of oxygen metabolites on cardiac sodium pump.

Authors:  Z J Xie; Y H Wang; A Askari; W H Huang; J E Klaunig; A Askari
Journal:  J Mol Cell Cardiol       Date:  1990-08       Impact factor: 5.000

4.  The cytosolic phospholipase A2 pathway, a safeguard of beta2-adrenergic cardiac effects in rat.

Authors:  Bouziane Ait-Mamar; Michel Cailleret; Catherine Rucker-Martin; Anissa Bouabdallah; Gabriele Candiani; Christophe Adamy; Philippe Duvaldestin; Francoise Pecker; Nicole Defer; Catherine Pavoine
Journal:  J Biol Chem       Date:  2005-02-22       Impact factor: 5.157

5.  Radioligand binding to muscle homogenates to quantify receptor and ion channel numbers.

Authors:  L L Bambrick; S E Howlett; Z P Feng; T Gordon
Journal:  J Pharmacol Methods       Date:  1988-12

6.  Chronic nitric oxide inhibition with L-NAME: effects on autonomic control of the cardiovascular system.

Authors:  K E Scrogin; D C Hatton; Y Chi; F C Luft
Journal:  Am J Physiol       Date:  1998-02

7.  Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice.

Authors:  Hiromi Jo; Hajime Otani; Fusakazu Jo; Takayuki Shimazu; Toru Okazaki; Kei Yoshioka; Masanori Fujita; Atsushi Kosaki; Toshiji Iwasaka
Journal:  Clin Exp Pharmacol Physiol       Date:  2011-08       Impact factor: 2.557

8.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

Authors:  E G Shesely; N Maeda; H S Kim; K M Desai; J H Krege; V E Laubach; P A Sherman; W C Sessa; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

9.  Lack of evidence for regulation of cardiac P-type ATPases and MAP kinases in transgenic mice with cardiac-specific overexpression of constitutively active alpha(1B)-adrenoceptors.

Authors:  F Barreto; D C Rezende; C B V Scaramello; C L M Silva; V M N Cunha; A Caricati-Neto; A Jurkiewicz; F Noël; L E M Quintas
Journal:  Braz J Med Biol Res       Date:  2010-04-16       Impact factor: 2.590

10.  Sodium and ATP affinities of the cardiac (Na,K)-ATPase in relation to nitric oxide synthesis in spontaneously hypertensive rats.

Authors:  Norbert Vrbjar; Olga Pechánová
Journal:  Life Sci       Date:  2002-08-30       Impact factor: 5.037

View more
  1 in total

1.  Effects of γ-irradiation on Na,K-ATPase in cardiac sarcolemma.

Authors:  L Mézešová; J Vlkovičová; B Kaločayová; V Jendruchová; M Barančík; M Fülöp; J Slezák; P Babál; P Janega; N Vrbjar
Journal:  Mol Cell Biochem       Date:  2013-12-18       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.